Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study
Crossref DOI link: https://doi.org/10.1186/1477-7819-12-171
Published Online: 2014-06-02
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dong, Qian
Yang, Xiang-hong
Zhang, Yao
Jing, Wei
Zheng, Li-qiang
Liu, Yun-peng
Qu, Xiu-juan
Article History
Received: 30 August 2013
Accepted: 16 May 2014
First Online: 2 June 2014